Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies

Youssuf Khanafer, Ayman Dalol, Ahmed Z. El-Hashim, Ibrahim F. Benter, Saghir Akhtar

Open source

DOI
10.3389/fphar.2026.1789833
Published
2026-08-03
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1789833,
  title = {Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies},
  author = {Youssuf Khanafer and Ayman Dalol and Ahmed Z. El-Hashim and Ibrahim F. Benter and Saghir Akhtar},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1789833},
  url = {https://doi.org/10.3389/fphar.2026.1789833}
}

RIS

TY  - JOUR
TI  - Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies
AU  - Youssuf Khanafer
AU  - Ayman Dalol
AU  - Ahmed Z. El-Hashim
AU  - Ibrahim F. Benter
AU  - Saghir Akhtar
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1789833
UR  - https://doi.org/10.3389/fphar.2026.1789833
ER  - 

APA

Khanafer, Y., Dalol, A., El-Hashim, A. Z., Benter, I. F., & Akhtar, S. (2026). Angiotensin-(1-7) in asthma and pulmonary fibrosis: mechanisms of action, clinical safety, and nano-delivery strategies. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1789833

Source records